| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/22/2005 | EP1414299A4 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
| 06/22/2005 | EP1196188B1 Vgf selective monoclonal antibodies and their use for treating vgf-related disorders |
| 06/22/2005 | EP1165763B1 Hydantoinase variants with improved properties and their use for the production of amino acids |
| 06/22/2005 | EP1124849B1 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 06/22/2005 | EP1017797B1 Non-primate lentiviral vectors and packaging systems |
| 06/22/2005 | EP0927254B1 Antagonists of interleukin-15 |
| 06/22/2005 | EP0791066B1 Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules |
| 06/22/2005 | EP0758397B1 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 06/22/2005 | CN2705462Y Peripheral nervous graft of tissue engineering |
| 06/22/2005 | CN1630731A Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 06/22/2005 | CN1630730A Methods for detecting and treating the early onset of aging-related conditions |
| 06/22/2005 | CN1630727A Nucleic acid for a cloning vector |
| 06/22/2005 | CN1630722A Adapter-directed display systems |
| 06/22/2005 | CN1630720A Bifunctional fusion proteins with glucocerebrosidase activity |
| 06/22/2005 | CN1630719A Phytase variants |
| 06/22/2005 | CN1630718A Improved isoprenoid production |
| 06/22/2005 | CN1630717A Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood and differentation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into |
| 06/22/2005 | CN1630716A Hematopoietic cells from human embryonic stem cells |
| 06/22/2005 | CN1630715A Methods of preparing a transplantable product for treatment of skin defects |
| 06/22/2005 | CN1630714A Circadian control of stem/progenitor cell self-renewal and differentiation and of clock controlled gene expression |
| 06/22/2005 | CN1630713A Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 06/22/2005 | CN1630712A Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 06/22/2005 | CN1630708A Osteoclast-associated receptor |
| 06/22/2005 | CN1630707A Systems and methods for rapidly changing the solution environment around sensors |
| 06/22/2005 | CN1630666A Factor VIII2 C2 domain variants |
| 06/22/2005 | CN1630665A Anti-A beta antibodies and their use |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630529A B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies |
| 06/22/2005 | CN1630526A Systems and methods for treating patients with processed lipoaspirate cells |
| 06/22/2005 | CN1629285A Natural killer cell for transgenic expression cell chemotactic factors |
| 06/22/2005 | CN1629284A A method for extracorporally constructing engineering valves of homogeneity biological heart tissue |
| 06/22/2005 | CN1207387C Polypeptides and genes encoding same |
| 06/22/2005 | CN1207385C Method for culturing wheat tissue capable of overcoming gene disturbance |
| 06/22/2005 | CN1207060C Absorbable calcined-bone preparation method |
| 06/21/2005 | US6909033 Soybean variety S03-95341-A98-60618 |
| 06/21/2005 | US6908993 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents |
| 06/21/2005 | US6908988 Animal models; medical diagnosis; antitumor agents |
| 06/21/2005 | US6908987 Comprises nucleotide sequences coding peroxisome proliferator activator receptor protein (PCG) for modulating thermogenesis in adipocytes and treating obesity |
| 06/21/2005 | US6908764 Recombinant human cell for bone and cartilage cell formation |
| 06/21/2005 | US6908763 Mammalian common lymphoid progenitor cell |
| 06/21/2005 | US6908736 DNA sequencing method |
| 06/21/2005 | US6908612 Virus coat protein/receptor chimeras and methods of use |
| 06/21/2005 | US6908610 Stable granulocyte colony stimulating factor formulation containing one or more of lysine, histidine, arginine, aspartic acid, glutamic acid, threonine and asparagine; one or more hydrophobic amino acids; and methionine |
| 06/21/2005 | CA2304926C Robo: a family of polypeptides and nucleic acids involved in nerve guidance |
| 06/21/2005 | CA2239070C Systems and methods for removing viral agents from blood |
| 06/21/2005 | CA2145005C Monoclonal antibodies specific for tcf-ii |
| 06/19/2005 | CA2494572A1 Cytochrome p450 24 (cyp24) monoclonal antibody and methods and uses thereof |
| 06/18/2005 | CA2450000A1 Method of creating plants with reduced level of saturated fatty acid in seed oil |
| 06/16/2005 | WO2005054808A2 Method for sex biasing spermatozoa |
| 06/16/2005 | WO2005054467A1 EXPRESSION SYSTEM WITH THE USE OF MAMMALIAN β-ACTIN PROMOTER |
| 06/16/2005 | WO2005054465A1 Method of obtaining gene tag |
| 06/16/2005 | WO2005054459A1 Process for producing hematopoietic stem cells or vascular endothelial precursor cells |
| 06/16/2005 | WO2005054458A1 Method for analyzing nucleic acid, cell for analyzing nucleic acid, and analyzer for nucleic acid |
| 06/16/2005 | WO2005054450A1 Compositions comprising fetal liver cells and methods useful for hcv infection |
| 06/16/2005 | WO2005054449A1 Use of il-6-type cytokines for maturation of oocytes |
| 06/16/2005 | WO2005054448A1 A novel process and method for deriving cardiomyocyte precursors from bone-marrow stem cells |
| 06/16/2005 | WO2005054447A2 Müller stem cells |
| 06/16/2005 | WO2005054446A2 Use of polysulphated alginate in cellular matrices |
| 06/16/2005 | WO2005054445A1 A method for isolating a self-renewing, multipotent slow-cycling cell |
| 06/16/2005 | WO2005054440A2 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan |
| 06/16/2005 | WO2005054424A2 Bioactive boxes for cellular cultures |
| 06/16/2005 | WO2005054296A1 Antibodies recognizing methyllysine, process for producing the same and utilization thereof |
| 06/16/2005 | WO2005053763A1 Hair growth method |
| 06/16/2005 | WO2005053601A2 Methods of generating stem cells and embryonic bodies carrying disease-causing mutations and methods of using same for studying genetic disorders |
| 06/16/2005 | WO2005053383A1 Method of ex vitro sowing, germination, growth and conversion of plant somatic embryos or germinants, and nutrient medium used therefor |
| 06/16/2005 | WO2005040333A3 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 06/16/2005 | WO2005035735A3 Programmable scaffold, and methods for making and using the same |
| 06/16/2005 | WO2005033144A3 Tim-3 polypeptides |
| 06/16/2005 | WO2005028639A3 Environments that maintain function of primary liver cells |
| 06/16/2005 | WO2005027633A3 Methods and compositions for the cryopreservation of organs |
| 06/16/2005 | WO2005018650A3 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent |
| 06/16/2005 | WO2005013899A9 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/16/2005 | WO2005005598A3 B. anthracis luxs and furanone inhibition of a1-2 quorum sensing |
| 06/16/2005 | WO2004108840A8 Nucleotides for prevention and treatment of bacterial and fungal pathologies |
| 06/16/2005 | WO2004094476A3 Compositions and methods relating to stop-1 |
| 06/16/2005 | WO2004084816A3 IMPROVED CD4-IgG2 FORMULATIONS |
| 06/16/2005 | WO2004053072A3 Administration of dendritic cells partially matured in vitro for the treatment of tumors |
| 06/16/2005 | WO2004050013A3 Material compositions and related systems and methods for treating cardiac conditions |
| 06/16/2005 | WO2004037195A3 Treatment of diabetes |
| 06/16/2005 | WO2004035006A3 Methods and compositions for immunization against hiv |
| 06/16/2005 | WO2004002428A3 Derivatives of gambogic acid and induce apoptosis |
| 06/16/2005 | US20050132453 Hybrid maize 36W66 |
| 06/16/2005 | US20050132452 Hybrid maize 38T41 |
| 06/16/2005 | US20050132447 Solely pollen-specific promoter |
| 06/16/2005 | US20050132445 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants |
| 06/16/2005 | US20050132442 Expression vector comprising nucleotide sequences coding fungal fatty acid desaturase for use in generating transgenic organism with enhanced concentrations of alpha-linolenic acid |
| 06/16/2005 | US20050132441 Delta15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast |
| 06/16/2005 | US20050132438 Expression vector comprising nucleotide sequence coding modulator which induces systemic aquired resistance in plants for use in generation and propagation of disease resistant plants |
| 06/16/2005 | US20050132431 Propagating mycorrhizal fungus in nutrient broth with subsequent incubation with root system to generate root/fungus symbiont to be used as in vitro model for study of mycorrhizal colonization |
| 06/16/2005 | US20050132430 Igamete recruitment and developmental competence in mammals by inhibiting the de-nova sterol biosynthesis and/or promoting sterol efflux |
| 06/16/2005 | US20050132428 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 06/16/2005 | US20050132426 Using nuclear transplantation to generate non-human embryo from transferred nucleus of neural stem cell; gene targeting; knockout mutants |
| 06/16/2005 | US20050131216 Reagents for detecting efavirenz |
| 06/16/2005 | US20050131212 Neurogenic peptide for use in enhancement of neuronal migration, proliferation, survival, differentiation, and/or neurite outgrowth |
| 06/16/2005 | US20050130922 Method and compositions for inhibiting tumorigenesis |
| 06/16/2005 | US20050130920 Promotes a prolonged, directed cytotoxic T cell response to the target cell; cancer; vaccine |
| 06/16/2005 | US20050130899 Tumor antigens |
| 06/16/2005 | US20050130889 Analog further comprises an amino acid substitution wherein the cysteine residue at BPI amino acid position 132 is replaced by another amino acid; for treating gram-negative bacterial infections in a subject; bactericidal for gram-positive bacteria and mycoplasma; enhances effectiveness of antibiotics |
| 06/16/2005 | US20050130886 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit |
| 06/16/2005 | US20050130320 Using antibody imaging to determine concentration and distribution of proteins in cells and tissues; immunoaffinity chromatography |